Eve Burstein
Stock Analyst at Bernstein
(2.63)
# 2,046
Out of 5,132 analysts
24
Total ratings
46.15%
Success rate
24.29%
Average return
Main Sectors:
Stocks Rated by Eve Burstein
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| A Agilent Technologies | Maintains: Market Perform | $145 → $125 | $124.88 | +0.10% | 5 | Apr 16, 2025 | |
| NTRA Natera | Maintains: Outperform | $160 → $200 | $207.84 | -3.77% | 4 | Jan 10, 2025 | |
| RVTY Revvity | Maintains: Outperform | $150 → $145 | $95.57 | +51.72% | 2 | Nov 5, 2024 | |
| WAT Waters | Maintains: Market Perform | $345 → $360 | $319.83 | +12.56% | 2 | Nov 4, 2024 | |
| EXAS Exact Sciences | Maintains: Outperform | $75 → $90 | $103.23 | -12.82% | 2 | Oct 30, 2024 | |
| GH Guardant Health | Maintains: Outperform | $40 → $35 | $102.76 | -65.94% | 2 | Oct 30, 2024 | |
| TMO Thermo Fisher Scientific | Maintains: Market Perform | $625 → $620 | $509.82 | +21.61% | 3 | Oct 24, 2024 | |
| PACB Pacific Biosciences of California | Maintains: Outperform | $9 → $2.5 | $1.84 | +35.87% | 2 | Apr 18, 2024 | |
| AVTR Avantor | Initiates: Market Perform | $22 | $9.14 | +140.70% | 1 | Sep 28, 2023 | |
| ILMN Illumina | Initiates: Underperform | $111 | $114.44 | -3.01% | 1 | Sep 28, 2023 |
Agilent Technologies
Apr 16, 2025
Maintains: Market Perform
Price Target: $145 → $125
Current: $124.88
Upside: +0.10%
Natera
Jan 10, 2025
Maintains: Outperform
Price Target: $160 → $200
Current: $207.84
Upside: -3.77%
Revvity
Nov 5, 2024
Maintains: Outperform
Price Target: $150 → $145
Current: $95.57
Upside: +51.72%
Waters
Nov 4, 2024
Maintains: Market Perform
Price Target: $345 → $360
Current: $319.83
Upside: +12.56%
Exact Sciences
Oct 30, 2024
Maintains: Outperform
Price Target: $75 → $90
Current: $103.23
Upside: -12.82%
Guardant Health
Oct 30, 2024
Maintains: Outperform
Price Target: $40 → $35
Current: $102.76
Upside: -65.94%
Thermo Fisher Scientific
Oct 24, 2024
Maintains: Market Perform
Price Target: $625 → $620
Current: $509.82
Upside: +21.61%
Pacific Biosciences of California
Apr 18, 2024
Maintains: Outperform
Price Target: $9 → $2.5
Current: $1.84
Upside: +35.87%
Avantor
Sep 28, 2023
Initiates: Market Perform
Price Target: $22
Current: $9.14
Upside: +140.70%
Illumina
Sep 28, 2023
Initiates: Underperform
Price Target: $111
Current: $114.44
Upside: -3.01%